In this video, Peter Zandstra of University of British Columbia, BC, Canada highlights his recent keynote on ‘Bottom-up and top-down engineering of stem cells fate for discovery and therapy’ that he presented at the recent European Society for Animal Cell Technology (ESACT) meeting in May 2019. Peter also provides an overview of the research being undertaken at his lab and discusses his hopes and dreams for the field.
About the author:
Dr. Peter Zandstra is Professor, Biomedical Research Centre, at the University of British Columbia, Canada. His vision is to translate the biological properties and potential of stem cells into useful applications that benefit society. Zandstra has focused his career on the development of, and contributions to, the field of “Stem Cell Bioengineering”, a term first used in a 2001 article by Zandstra and Andras Nagy (Lunenfeld-Tanenbaum Research Institute, Canada) and which is defined as an endeavor focused on the quantitative control of stem cell fate and the development of technologies for stem cell-based therapies. Research in the Zandstra Laboratory is, therefore, focused on the generation of functional tissue from adult and pluripotent stem cells. His groups’ quantitative, bioengineering-based approach strives to gain new insight into the fundamental mechanisms that control stem cell fate and to develop robust technologies for the use of stem cells and their derivatives to treat disease. Specific areas of research focus include blood stem cell expansion and the generation of cardiac tissue and blood progenitors from pluripotent stem cells. Find out more here.
Video originally published on BioTechniques, a journal and digital platform from the Future Science Group providing the life science research community with an invaluable resource to access latest methods, techniques and protocols.